High-dose chemotherapy for breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
http://www.nature.com/articles/1702597.pdf
Reference5 articles.
1. Lippman ME . High dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer New Engl J Med 2000 342: 1119–1120
2. Stadtmauer EA, O'Neill A, Goldstein LJ et al. Conventional dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem cell transplantation for metastatic breast cancer New Engl J Med 2000 342: 1069–1076
3. Gratwohl A, Passweg J, Baldomero H, Hermans J . Special report: Blood and marrow transplantation activity in Europe 1997 Bone Marrow Transplant 1999 24: 231–245
4. Antman K, Ayash L, Elias A et al. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy J Clin Oncol 1992 10: 102–110
5. NIH News Release. Don't write off high-dose chemotherapy with bone marrow transplant for breast cancer, experts say. http://www.nih.gov/news/pr/may2000/nci-19.htm
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2016-11-07
2. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation;Bone Marrow Transplantation;2007-01
3. Symptom distress, functional status and health-related quality of life before high-dose chemotherapy with stem-cell transplantation;European Journal of Cancer Care;2003-03
4. Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe;British Journal of Haematology;2002-04-25
5. Re: Stem Cell Transplant Numbers Decline; Research Continues;JNCI Journal of the National Cancer Institute;2001-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3